Institutional Ownership
Milestone Pharmaceuticals In
CUSIP 59935V107COMMISTQ1 2026
13D / 13G Filings
49
Schedule 13D/13G on record
Beneficial Filers
21
Distinct reporting persons
Largest Stake
16.2%
Max % of class reported
Institutional Holders
85
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
49 filings · latest Dec 23, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 23, 2025 | Propel Bio Management, LLC | 13G | 9.9% | — | SEC |
| 2 | Nov 14, 2025 | Rtw Investments, LP | 13G/A | 9.9% | 9.16M | SEC |
| 3 | Nov 14, 2025 | Trails Edge Capital Partners, LP | 13G/A | 9.9% | 9.02M | SEC |
| 4 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G | 10.0% | 8.66M | SEC |
| 5 | Jul 21, 2025 | Trails Edge Capital Partners, LP | 13G | 9.9% | 8.85M | SEC |
| 6 | Apr 30, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 322.1K | SEC |
| 7 | Apr 22, 2025 | Blackrock, Inc. | 13G/A | — | — | SEC |
| 8 | Feb 14, 2025 | Rtw Investments, LP | 13G/A | 10.0% | 5.64M | SEC |
| 9 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 7.6% | 4.05M | SEC |
| 10 | Oct 29, 2024 | Integrated Core Strategies (Us) LLC | 13G/A | 5.1% | 2.74M | SEC |
39 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Milestone Pharmaceuticals In.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rtw Investments, LP | 6.33M | $7.53M |
| 2 | Propel Bio Management, LLC | 4.12M | $5.08M |
| 3 | Two Sigma Investments, LP | 2.32M | $2.76M |
| 4 | Goldman Sachs Group Inc | 2.00M | $2.38M |
| 5 | Marshall Wace, LLP | 1.94M | $2.31M |
| 6 | Millennium Management LLC | 1.54M | $1.84M |
| 7 | Simplify Asset Management Inc. | 1.51M | $1.79M |
| 8 | Point72 Asset Management, L.P. | 1.09M | $1.29M |
| 9 | Balyasny Asset Management L.P. | 851.3K | $1.01M |
| 10 | Lion Point Capital, LP | 820.0K | $975.8K |